Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

24.87

-0.12 (-0.48%)

Aug 14, 2025, 2:24 PM - Market open

Celldex Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	1,652	1,677	2,169	2,099	1,803	693	Upgrade
Market Cap Growth	-44.61%	-22.71%	3.32%	16.42%	160.10%	1759.97%	Upgrade
Enterprise Value	1,018	924	1,936	1,779	1,383	497	Upgrade
Last Close Price	24.99	25.27	39.66	44.57	38.64	17.52	Upgrade
PS Ratio	286.44	238.82	315.12	890.64	387.68	93.45	Upgrade
PB Ratio	2.53	2.24	5.05	6.44	4.30	3.31	Upgrade
P/TBV Ratio	2.62	2.33	5.40	7.02	4.60	3.88	Upgrade
EV/Sales Ratio	175.86	131.57	281.34	754.94	297.37	67.06	Upgrade
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.02	Upgrade
Asset Turnover	0.01	0.01	0.02	0.01	0.01	0.04	Upgrade
Quick Ratio	19.13	18.38	13.69	16.41	24.71	13.81	Upgrade
Current Ratio	19.67	18.92	13.87	17.07	24.86	13.93	Upgrade
Return on Equity (ROE)	-27.18%	-26.84%	-37.45%	-30.13%	-22.43%	-39.41%	Upgrade
Return on Assets (ROA)	-19.08%	-19.38%	-21.70%	-16.79%	-12.70%	-17.27%	Upgrade
Return on Capital (ROIC)	-19.90%	-20.62%	-23.30%	-17.78%	-13.60%	-19.96%	Upgrade
Earnings Yield	-12.13%	-9.42%	-6.52%	-5.35%	-3.91%	-8.62%	Upgrade
FCF Yield	-11.45%	-9.53%	-5.03%	-5.03%	-3.45%	-6.05%	Upgrade
Buyback Yield / Dilution	-18.39%	-32.91%	-3.33%	-9.37%	-44.64%	-104.31%	Upgrade

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q